Literature DB >> 7111679

The acromegaly syndrome. Relation between clinical features, growth hormone values and radiological characteristics of the pituitary tumours.

A Jadresic, L M Banks, D F Child, L Diamant, F H Doyle, T R Fraser, G F Joplin.   

Abstract

One hundred and fifty-five acromegalics, 76 males (mean age 44 +/- 1.3 years) and 79 females (45 +/- 1.4 years) were studied. The frequency of clinical features were: acral enlargement 100 per cent, hyperhidrosis 65 per cent, headache 55 per cent, paraesthesiae 49 per cent, cardiac problems 34 per cent, hypertension 32 per cent, diabetes mellitus (clinical and chemical) 27 per cent, and visual field defects 6 per cent. Signs and symptoms, and particularly headache, did not show any relation with the size or shape of pituitary tumours, nor with growth hormone (GH) values, age, sex or weight. Mean of GH values at 60, 90 and 120 minutes during a GTT averaged 135 mIU/l, range 8-1833. Diabetes mellitus was more frequent and severe in patients with higher GH values, occurring in 32 per cent of patients with mean GH values greater than or equal to 50 mIU/l and only in 16 per cent of the rest (p less than 0.05). GH values correlated positively with size of tumours. Forty-nine per cent of patients presented with entirely intrasellar tumours, 27 per cent with suprasellar extensions and 23 per cent with partially empty sellae. The mean GH (238 mIU/l) of patients with suprasellar extensions was significantly higher (p less than 0.004) than those of the others. Younger acromegalics showed a tendency to larger tumours. Early treatment of acromegaly, particularly in young patients and those presenting with high GH values, is recommended.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7111679

Source DB:  PubMed          Journal:  Q J Med        ISSN: 0033-5622


  41 in total

Review 1.  The somatotropic axis and longevity in mice.

Authors:  H M Brown-Borg
Journal:  Am J Physiol Endocrinol Metab       Date:  2015-07-28       Impact factor: 4.310

Review 2.  Acromegaly.

Authors:  Anat Ben-Shlomo; Shlomo Melmed
Journal:  Endocrinol Metab Clin North Am       Date:  2008-03       Impact factor: 4.741

3.  Female gonadal functions and ovarian reserve in patients with acromegaly: experience from a single tertiary center.

Authors:  Sema Ciftci Dogansen; Seher Tanrikulu; Gulsah Yenidunya Yalin; Sema Yarman
Journal:  Endocrine       Date:  2018-02-05       Impact factor: 3.633

4.  [Other specific types of diabetes].

Authors:  Greisa Vila; Alois W Gessl; Michaela Riedl; Anton Luger
Journal:  Wien Klin Wochenschr       Date:  2016-04       Impact factor: 1.704

5.  Transgene transmission to progeny by oMt1a-oGH transgenic mice.

Authors:  A D Thomas; J D Murray; A M Oberbauer
Journal:  Transgenic Res       Date:  2005-08       Impact factor: 2.788

6.  Acromegaly and hypertension: prevalence and relationship to the renin-angiotensin-aldosterone system.

Authors:  C Kraatz; G Benker; F Weber; D Lüdecke; H Hirche; D Reinwein
Journal:  Klin Wochenschr       Date:  1990-06-19

Review 7.  Somatotropic signaling: trade-offs between growth, reproductive development, and longevity.

Authors:  Andrzej Bartke; Liou Y Sun; Valter Longo
Journal:  Physiol Rev       Date:  2013-04       Impact factor: 37.312

Review 8.  Links between growth hormone and aging.

Authors:  Andrzej Bartke; Reyhan Westbrook; Liou Sun; Mariusz Ratajczak
Journal:  Endokrynol Pol       Date:  2013       Impact factor: 1.582

9.  Hyperostosis frontalis interna, acromegaly and hyperprolactinaemia.

Authors:  J D Fulton; J Shand; D Ritchie; J McGhee
Journal:  Postgrad Med J       Date:  1990-01       Impact factor: 2.401

Review 10.  Growth hormone and aging: a challenging controversy.

Authors:  Andrzej Bartke
Journal:  Clin Interv Aging       Date:  2008       Impact factor: 4.458

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.